[Comparison of the early analgesic efficacy of three different drugs after anterior cruciate ligament reconstruction].

Q3 Medicine 北京大学学报(医学版) Pub Date : 2024-04-18
Jiangjing Wang, Shunyi Wei, Yingfang Ao, Yuping Yang
{"title":"[Comparison of the early analgesic efficacy of three different drugs after anterior cruciate ligament reconstruction].","authors":"Jiangjing Wang, Shunyi Wei, Yingfang Ao, Yuping Yang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The pain-relieving effect and safety of compound aminopyrine phenacetin tablets, tramcontin (tramadol hydrochloride sustained-release tablets) and dolantin in the early stage of autologous tendon reconstruction of the anterior cruciate ligament (ACL) of the knee joint were compared.</p><p><strong>Methods: </strong>Retrospective analysis of postoperative pain and drug analgesia in 45 patients performed by the same group from November 2018 to February 2019. The random area group design was divided into two groups according to whether ACL rupture was combined with meniscal injury, group A was 24 patients with ACL reconstruction of knee joint and group B was 21 patients with ACL fracture combined with meniscus injury. The two groups were divided into three subgroups respectively according to the actual treatment of postoperative analgesic drugs received by the patients, including 4 cases of compound aminopyrine phenacetin tablets, 11 cases of oral tramcontin, 9 cases of intramuscular dolantin combined with phenergan in group A; 3 cases of compound aminopyrine phenacetin tablets, 10 cases of oral tramcontin, and 8 cases of intramuscular dolantin combined with phenergan in group B. When the early postoperative patients complain about pain and actively ask for analgesia. When the patients complained about pain after the operation and actively asked for analgesia, they were randomly given painkillers, tramcontin or dolantin combined with phenergan to relieve pain. Pain visual analogue scale (VAS) was used to evaluate pain relief and observe the occurrence of adverse reactions.</p><p><strong>Results: </strong>There were no significant dif-ferences in gender, age, body mass index, and time of hospital stay between the two groups of patients (<i>P</i> > 0.05). In the patients who used tramcontin and dolantin combined with phenergan to relieve pain judging by VAS score before and 1 h after taking the drug, it was found that the pain situation of the patient was significantly relieved, and the difference before and after taking the drug had statistical significance (<i>P</i> < 0.05). Pairwise comparisons of the three drugs applied in the two groups showed significantly greater pain relief in the dolantin combined with phenergan group than in the remaining two drugs. There was no significant difference (<i>P</i> > 0.05). Dolantin was prone to nausea and vomiting, but the application of phenergan was also used to reduce side effects. In terms of adverse reactions, only 1 case of nausea occurred in the tramcontin group for simple ACL reconstruction, and none of the patients in the other groups showed serious complications and allergic reactions.</p><p><strong>Conclusion: </strong>Whether in cruciate ligament reconstruction alone or combined with meniscus molding or suture, compound aminopyrine phenacetin tablets, tramcontin, dolantin combined with phenergan can effectively relieve pain. Among the three drugs, dolantin caused the largest pain relief. At the same time, the combination of phenergan effectively reduced the adverse reactions, such as vomiting and nausea, and increased the drug safety.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11004950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"北京大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The pain-relieving effect and safety of compound aminopyrine phenacetin tablets, tramcontin (tramadol hydrochloride sustained-release tablets) and dolantin in the early stage of autologous tendon reconstruction of the anterior cruciate ligament (ACL) of the knee joint were compared.

Methods: Retrospective analysis of postoperative pain and drug analgesia in 45 patients performed by the same group from November 2018 to February 2019. The random area group design was divided into two groups according to whether ACL rupture was combined with meniscal injury, group A was 24 patients with ACL reconstruction of knee joint and group B was 21 patients with ACL fracture combined with meniscus injury. The two groups were divided into three subgroups respectively according to the actual treatment of postoperative analgesic drugs received by the patients, including 4 cases of compound aminopyrine phenacetin tablets, 11 cases of oral tramcontin, 9 cases of intramuscular dolantin combined with phenergan in group A; 3 cases of compound aminopyrine phenacetin tablets, 10 cases of oral tramcontin, and 8 cases of intramuscular dolantin combined with phenergan in group B. When the early postoperative patients complain about pain and actively ask for analgesia. When the patients complained about pain after the operation and actively asked for analgesia, they were randomly given painkillers, tramcontin or dolantin combined with phenergan to relieve pain. Pain visual analogue scale (VAS) was used to evaluate pain relief and observe the occurrence of adverse reactions.

Results: There were no significant dif-ferences in gender, age, body mass index, and time of hospital stay between the two groups of patients (P > 0.05). In the patients who used tramcontin and dolantin combined with phenergan to relieve pain judging by VAS score before and 1 h after taking the drug, it was found that the pain situation of the patient was significantly relieved, and the difference before and after taking the drug had statistical significance (P < 0.05). Pairwise comparisons of the three drugs applied in the two groups showed significantly greater pain relief in the dolantin combined with phenergan group than in the remaining two drugs. There was no significant difference (P > 0.05). Dolantin was prone to nausea and vomiting, but the application of phenergan was also used to reduce side effects. In terms of adverse reactions, only 1 case of nausea occurred in the tramcontin group for simple ACL reconstruction, and none of the patients in the other groups showed serious complications and allergic reactions.

Conclusion: Whether in cruciate ligament reconstruction alone or combined with meniscus molding or suture, compound aminopyrine phenacetin tablets, tramcontin, dolantin combined with phenergan can effectively relieve pain. Among the three drugs, dolantin caused the largest pain relief. At the same time, the combination of phenergan effectively reduced the adverse reactions, such as vomiting and nausea, and increased the drug safety.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[前十字韧带重建术后三种不同药物的早期镇痛效果比较]。
目的:比较复方氨酚黄那敏片、曲康定(盐酸曲马多缓释片)和多兰婷在膝关节前交叉韧带(ACL)自体肌腱重建术早期的镇痛效果和安全性:回顾性分析2018年11月-2019年2月同组45例患者术后疼痛及药物镇痛情况。随机区组设计,根据前交叉韧带断裂是否合并半月板损伤分为两组,A组为膝关节前交叉韧带重建患者24例,B组为前交叉韧带断裂合并半月板损伤患者21例。根据患者实际接受的术后镇痛药物治疗情况,将两组患者分别分为三个亚组,其中 A 组患者使用复方氨基比林苯乙双胍片 4 例,口服曲安奈德 11 例,肌肉注射多兰丁联合苯乙双胍 9 例;B 组患者使用复方氨基比林苯乙双胍片 3 例,口服曲安奈德 10 例,肌肉注射多兰丁联合苯乙双胍 8 例。术后早期患者主诉疼痛并主动要求镇痛时。当患者在术后主诉疼痛并主动要求镇痛时,随机给予他们止痛药、曲康定或多兰婷联合苯乙双胍以缓解疼痛。采用疼痛视觉模拟量表(VAS)评估疼痛缓解情况,并观察不良反应的发生情况:两组患者在性别、年龄、体重指数和住院时间上无明显差异(P>0.05)。在使用曲安奈德和多兰婷联合苯乙双胍缓解疼痛的患者中,通过服药前和服药后 1 h 的 VAS 评分,发现患者的疼痛情况明显缓解,服药前后的差异有统计学意义(P < 0.05)。对两组应用的三种药物进行配对比较发现,多兰婷联合苯乙双胍组的疼痛缓解程度明显高于其余两种药物。没有明显差异(P>0.05)。多兰婷容易引起恶心和呕吐,但应用 phenergan 也可减少副作用。在不良反应方面,仅有1例恶心发生在前交叉韧带简单重建的曲康定组,其他组患者均未出现严重并发症和过敏反应:结论:无论是单纯的十字韧带重建,还是结合半月板成型或缝合,复方氨基比林苯乙双胍片、曲康定、多兰婷联合苯乙双胍都能有效缓解疼痛。在这三种药物中,多兰婷的止痛效果最好。同时,联合使用 phenergan 有效减少了呕吐、恶心等不良反应,提高了用药安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
北京大学学报(医学版)
北京大学学报(医学版) Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
9815
期刊介绍:
期刊最新文献
[Clinical diagnosis and treatment of renal angiomyolipoma with inferior vena cava tumor thrombus]. [Clinical effects of transesophageal echocardiography in different surgical methods for nephrectomy combined with Mayo Ⅲ-Ⅳ vena tumor thrombectomy]. [Clinical treatment and prognosis of adrenocortical carcinoma with venous tumor thrombus]. [Construction of a predictive model for postoperative pain relief after microscopic spermatic cord surgery for spermatic cord pain]. [Association between the triglyceride-glucose index and the incidence of nephrolithiasis in male individuals].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1